Recruiting × Interventional × Esophageal Neoplasms × Clear all PSI-Immune
Phase 2 Recruiting
880 enrolled
Chemotherapy With or Without Radiation or Surgery in Treating Participants With Oligometastatic Esophageal or Gastric Cancer
Phase 2 Recruiting
100 enrolled
Dyadic Yoga Intervention in Improving Physical Performance and Quality of Life in Patients With Stage I-IV Non-small Cell Lung or Esophageal Cancer Undergoing Radiotherapy and Their Caregivers
Phase NA Recruiting
400 enrolled
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
450 enrolled
INS-ESCC-CT
Phase 2 Recruiting
118 enrolled
STELLAR01
Phase 2 Recruiting
98 enrolled
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Phase 1 Recruiting
694 enrolled
MK-3475-06C
Phase 1/2 Recruiting
160 enrolled
The Vanguard Study: Testing a New Way to Screen for Cancer
Phase NA Recruiting
24,000 enrolled
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
Phase 3 Recruiting
2,130 enrolled
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 Recruiting
200 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Phase 1 Recruiting
1,006 enrolled
A Study to Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors
Phase 1 Recruiting
310 enrolled
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
Phase NA Recruiting
420 enrolled
MK-3475-06D
Phase 1/2 Recruiting
210 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
Phase 1 Recruiting
280 enrolled
A Multicenter Prospective Study Evaluating Concurrent Chemoradiotherapy Following Induction Immunochemotherapy for Esophageal Cancer Based on Dynamic ctDNA Monitoring
Phase NA Recruiting
30 enrolled
CHANCES
Phase 1 Recruiting
27 enrolled
MK-3475-06B
Phase 1/2 Recruiting
230 enrolled
FiREBOLT
Phase 1 Recruiting
241 enrolled
SIEWERT-RCT
Phase NA Recruiting
120 enrolled
REACH
Phase NA Recruiting
257 enrolled
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
Phase 1 Recruiting
42 enrolled
FAPI-GO
Phase 3 Recruiting
200 enrolled
HEARTS Trial for Thoracic Cancers
Phase 2 Recruiting
60 enrolled
Combination of COMBO Endoscopy Oropharyngeal Airway and HFNC Oxygenation in Sedated Gastrointestinal Endoscopy for Morbidly Obese Patients
Phase NA Recruiting
410 enrolled
PEGASUS
Phase 2 Recruiting
30 enrolled
Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer
Phase 4 Recruiting
22 enrolled
Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA
Phase 2 Recruiting
40 enrolled
A Study of Bemosubaiabimab Combined With Anlotinib and Radiotherapy and Chemotherapy for the Treatment of Oligometastatic Esophageal Cancer
Phase 2 Recruiting
28 enrolled
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Phase 1 Recruiting
200 enrolled
Clinical Trial Evaluating TQB6411 Injection in Subjects With Esophageal Cancer
Phase 1/2 Recruiting
105 enrolled
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Phase 1/2 Recruiting
134 enrolled
IDOV-Immune for Advanced Solid Tumors
Phase 1 Recruiting
78 enrolled
Induction Immunochemotherapy Followed by Concurrent Chemoradiotherapy in Patients With ESCC.
Phase 2 Recruiting
60 enrolled
High-Flow Nasal Cannula for Preventing Hypoxia During Sedated Endoscopy in High-Risk Obstructive Sleep Apnea Patients
Phase NA Recruiting
600 enrolled
Exploratory Clinical Trial of Oral Paclitaxel Plus Radiotherapy in Patients With Locally Advanced Unresectable Esophageal Squamous Cell Carcinoma
Phase 2 Recruiting
22 enrolled
Endeavor-1
Phase NA Recruiting
50 enrolled
DG-03
Phase 2 Recruiting
450 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
MAGECmultiDiCE
Phase NA Recruiting
2,200 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
Effects of Bright-light Exposure Combined With Specific Exercise Training (BEST) Program in Patients With Cancer
Phase NA Recruiting
200 enrolled
MAGEC
Phase NA Recruiting
1,000 enrolled
PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
Phase NA Recruiting
20 enrolled
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Phase 1/2 Recruiting
534 enrolled
CCRT Followed by PD-1 Inhibitor Maintenance Therapy in Locally Advanced ESCC
Phase 3 Recruiting
452 enrolled
VISTA
Phase 1 Recruiting
45 enrolled